News & insights

Taylor Wessing advises founders of Transform8 GmbH on the sale and re-investment in H&Z Unternehmensberatung, a portfolio company of EMZ Partners

by multiple authors

Taylor Wessing advises 3spin Learning on growth financing by TÜV NORD GROUP

by multiple authors

145 days DSA for VLOPs: The takeaways for smaller service providers

by Alexander Schmalenberger, LL.B. and Dr. Gregor Schmid, LL.M. (Cambridge)

German insolvency administrator grossly negligent for breach of duty in investigating contestation claims

by Dr. Rembert T. Graf Kerssenbrock, LL.M. (Beijing)

Taylor Wessing advises delta pronatura group on the change of the legal form and the international reorganization of the group companies

by multiple authors

Taylor Wessing advises Sunday Natural on the sale of a stake to CVC

by multiple authors

11. January 2024 – CJEU Case C 473/22: Mylan AB v Gilead and others

Germany as a location for pharmaceutical businesses - quo vadis, 2024?

Strategy paper by the German Federal Government on improving the regulatory framework for the pharmaceutical industry in Germany

by Irina Rebin

Work/Life: international employment news update

by multiple authors